Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Institut Claudius Regaud
ClinicalTrials.gov Identifier:
NCT00144976
First received: September 2, 2005
Last updated: May 9, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)